BETALOC

This brand name is authorized in Australia, Croatia, Cyprus, Ecuador, Estonia, Hong Kong SAR China, Ireland, Lithuania, Malta, New Zealand, Nigeria, Poland, Romania, UK.

Active ingredients

The drug BETALOC contains one active pharmaceutical ingredient (API):

1
UNII W5S57Y3A5L - METOPROLOL TARTRATE
 

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation.

 
Read more about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BETALOC Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C07AB02 Metoprolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 1324Q, 1325R
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 27.695-1-03-12, 27.741-1-03-12
EE Ravimiamet 1012835, 1019719, 1019720, 1029934, 1072066, 1072077, 1083406, 1083417, 1149061, 1149072, 1149106, 1149117, 1832576, 1832598, 1871906
GB Medicines & Healthcare Products Regulatory Agency 36160
HK Department of Health Drug Office 19220, 19614, 19885, 30849, 30850, 34975, 49649
HR Agencija za lijekove i medicinske proizvode HR-H-148642958, HR-H-495596644, HR-H-965178809
LT Valstybinė vaistų kontrolės tarnyba 1002098, 1002099, 1003719, 1004945, 1005306, 1005307, 1010461, 1019766, 1027886, 1027887, 1060286, 1060287, 1072191, 1085825, 1087050
MT Medicines Authority AA565/35601
NG Registered Drug Product Database 04-6204, A4-6202, A4-6203
Switch country to Nigeria in order to find specific presentations of BETALOC
NZ Medicines and Medical Devices Safety Authority 7035, 7037, 7038, 9518
PL Rejestru Produktów Leczniczych 100009914, 100077784, 100077821, 100105948, 100254565, 100264931, 100264960, 100277738, 100277856, 100280120, 100296090, 100307988, 100310476, 100313658, 100314089, 100324521, 100325650, 100325667, 100333187, 100334146, 100336033, 100357839, 100358158, 100358170, 100360994, 100373904, 100374967, 100386500, 100387705, 100387734, 100400216, 100400506, 100400535, 100400676, 100400699, 100400995, 100403031, 100403522, 100403829, 100405691, 100405700, 100405975, 100413472, 100427600, 100435516, 100441379, 100444567, 100444886, 100448170, 100451176, 100454270, 100457646, 100462794, 100463582, 100468542
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66031001, W66032001, W66032002, W66032003, W66033001, W66033002, W66033003, W66034001, W66034002, W66034003, W66034004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.